These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8992999)
1. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. Kim JJ; Ayyavoo V; Bagarazzi ML; Chattergoon MA; Dang K; Wang B; Boyer JD; Weiner DB J Immunol; 1997 Jan; 158(2):816-26. PubMed ID: 8992999 [TBL] [Abstract][Full Text] [Related]
2. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550 [TBL] [Abstract][Full Text] [Related]
3. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. Okada E; Sasaki S; Ishii N; Aoki I; Yasuda T; Nishioka K; Fukushima J; Miyazaki J; Wahren B; Okuda K J Immunol; 1997 Oct; 159(7):3638-47. PubMed ID: 9317164 [TBL] [Abstract][Full Text] [Related]
4. [DNA vaccination of the induction of immune responses by codelivery of IL-12 expression vector with hepatitis C structural antigens]. Shan M; Liu K; Fang H Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):236-9. PubMed ID: 10715797 [TBL] [Abstract][Full Text] [Related]
5. Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes. Ahlers JD; Dunlop N; Alling DW; Nara PL; Berzofsky JA J Immunol; 1997 Apr; 158(8):3947-58. PubMed ID: 9103465 [TBL] [Abstract][Full Text] [Related]
6. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge. Sin JI; Kim JJ; Arnold RL; Shroff KE; McCallus D; Pachuk C; McElhiney SP; Wolf MW; Pompa-de Bruin SJ; Higgins TJ; Ciccarelli RB; Weiner DB J Immunol; 1999 Mar; 162(5):2912-21. PubMed ID: 10072541 [TBL] [Abstract][Full Text] [Related]
7. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner. Gherardi MM; Ramirez JC; Rodríguez D; Rodríguez JR; Sano G; Zavala F; Esteban M J Immunol; 1999 Jun; 162(11):6724-33. PubMed ID: 10352291 [TBL] [Abstract][Full Text] [Related]
8. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma. Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252 [TBL] [Abstract][Full Text] [Related]
9. CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines. Kim JJ; Nottingham LK; Sin JI; Tsai A; Morrison L; Oh J; Dang K; Hu Y; Kazahaya K; Bennett M; Dentchev T; Wilson DM; Chalian AA; Boyer JD; Agadjanyan MG; Weiner DB J Clin Invest; 1998 Sep; 102(6):1112-24. PubMed ID: 9739045 [TBL] [Abstract][Full Text] [Related]
10. DNA immune responses induced by codelivery of IL-12 expression vectors with hepatitis C structural antigens. Shan MM; Liu KZ; Fang HL; Chen Z Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):553-7. PubMed ID: 14607685 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. Geissler M; Gesien A; Tokushige K; Wands JR J Immunol; 1997 Feb; 158(3):1231-7. PubMed ID: 9013964 [TBL] [Abstract][Full Text] [Related]
12. 8 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine. Arai H; Xin KQ; Hamajima K; Lu Y; Watabe S; Takahashi T; Toda S; Okuda K; Kudoh I; Suzuki M; Okuda K Gene Ther; 2000 Apr; 7(8):694-702. PubMed ID: 10800093 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha. Jiang W; Ren L; Jin N J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910 [TBL] [Abstract][Full Text] [Related]
14. Effect of immunological adjuvants: GM-CSF (granulocyte-monocyte colony stimulating factor) and IL-23 (interleukin-23) on immune responses generated against hepatitis C virus core DNA vaccine. Hartoonian C; Ebtekar M; Soleimanjahi H; Karami A; Mahdavi M; Rastgoo N; Azadmanesh K Cytokine; 2009 Apr; 46(1):43-50. PubMed ID: 19278866 [TBL] [Abstract][Full Text] [Related]
16. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent. Wild J; Grusby MJ; Schirmbeck R; Reimann J J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922 [TBL] [Abstract][Full Text] [Related]
17. Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV. Kim JJ; Simbiri KA; Sin JI; Dang K; Oh J; Dentchev T; Lee D; Nottingham LK; Chalian AA; McCallus D; Ciccarelli R; Agadjanyan MG; Weiner DB J Interferon Cytokine Res; 1999 Jan; 19(1):77-84. PubMed ID: 10048771 [TBL] [Abstract][Full Text] [Related]
18. Engineering enhancement of immune responses to DNA-based vaccines in a prostate cancer model in rhesus macaques through the use of cytokine gene adjuvants. Kim JJ; Yang JS; Dang K; Manson KH; Weiner DB Clin Cancer Res; 2001 Mar; 7(3 Suppl):882s-889s. PubMed ID: 11300487 [TBL] [Abstract][Full Text] [Related]
19. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen. Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222 [TBL] [Abstract][Full Text] [Related]
20. DNA inoculation induces protective in vivo immune responses against cellular challenge with HIV-1 antigen-expressing cells. Wang B; Merva M; Dang K; Ugen KE; Boyer J; Williams WV; Weiner DB AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S35-41. PubMed ID: 7865331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]